Trial Profile
Multi-center, Investigator Initiated Phase 1 Study of NY-ESO-1 Specific TCR Gene Transduced T Lymphocytes Transfer for Patients with Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Dec 2021
Price :
$35
*
At a glance
- Drugs Mipetresgene autoleucel (Primary) ; Cyclophosphamide; Fludarabine
- Indications Solid tumours; Synovial sarcoma
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- Sponsors Takara Bio
- 04 Jun 2019 Status changed to completed as per results presented at the 55th Annual Meeting of the American Society of Clinical Oncology
- 04 Jun 2019 Results presented at the 55th Annual Meeting of the American Society of Clinical Oncology
- 19 Oct 2018 Status changed from recruiting to active, no longer recruiting.